# What This Resolution Actually Does

This is a symbolic resolution that says Congress recognizes Charcot-Marie-Tooth disease as an important health problem and believes the government should fund more research to fight it. It's not a law that forces anything to happen or allocates specific money—it's more like an official statement of support that Congress is putting on record.

Charcot-Marie-Tooth disease, or CMT, is a rare inherited nerve disorder that damages the nerves connecting your brain and spinal cord to the rest of your body. This causes weakness and numbness, usually starting in the feet and legs. About 126,000 Americans have it, and millions more worldwide. The resolution points out that researchers still haven't identified all the genes that cause different types of CMT, and there's currently no cure. The sponsors of this resolution noticed that federal funding for CMT research actually went down between 2021 and 2022, which they see as a problem.

By passing this resolution, the House is essentially saying that CMT deserves more attention and money from the National Institute of Neurological Disorders and Stroke, which is part of the National Institutes of Health. This could help raise awareness about the disease among policymakers and potentially influence future budget decisions, but the resolution itself doesn't guarantee any new funding will appear. It's a way for Congress to signal that rare diseases like CMT matter and should be a priority for research investment going forward.

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Gottheimer, Josh

<p>This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.</p>